文献速递神经肿瘤

脑肿瘤手术患者的衰弱:文献系统综述

Frailty in Patients Undergoing Surgery for Brain Tumors: A Systematic Review of the Literature.
PubMed 文献 · World Neurosurg · 2022-07-16

该研究通过检索多个数据库,纳入21项使用经验证工具评估衰弱的脑肿瘤手术患者研究,发现衰弱与死亡、生存、并发症、住院时间、费用、出院去向、再入院和手术时间等临床结局相关。但现有文献多为回顾性研究,衰弱定义、分级阈值和患者人群异质性大,需进一步研究最佳评估实践。

要点

  • 脑肿瘤手术患者中,衰弱评估常用5因子改良衰弱指数、11因子改良衰弱指数、约翰霍普金斯调整临床组衰弱定义诊断指标和霍普金斯衰弱评分。
  • 衰弱分级阈值多种多样,尚无统一标准。
  • 衰弱与死亡、生存、并发症、住院时间、费用、出院去向、再入院和手术时间等临床结局相关。

核心结论

  • 衰弱是脑肿瘤患者中日益流行的概念,与重要临床结局相关,但现有文献多为回顾性研究,衰弱定义、分级阈值和患者人群异质性大,需进一步研究最佳评估实践并应用于临床。

研究设计与样本

  • 系统综述,检索PubMed、Embase、Cochrane图书馆、Web of Science、Scopus和ClinicalTrials.gov,从753条引文中纳入21项研究,纳入标准为脑肿瘤患者、使用经验证工具评估衰弱并测量衰弱对术后结局的影响。

主要发现

  • 共纳入21项研究,评估的衰弱工具按报告频率依次为5因子改良衰弱指数、11因子改良衰弱指数、约翰霍普金斯调整临床组衰弱定义诊断指标和霍普金斯衰弱评分。
  • 报告了多种不同的区分衰弱水平的惯例和阈值。
  • 与衰弱相关的临床结局包括死亡、生存、并发症、住院时间、费用、出院去向、再入院和手术时间。

局限性

  • 现有文献主要由回顾性研究组成,衰弱定义、分级阈值和患者人群存在异质性。
  • 需要进一步研究以了解脑肿瘤患者衰弱评估的最佳实践,并将这些概念应用于临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging literature suggests that frailty may be an important driver of postoperative outcomes in patients undergoing surgery for brain tumors. We systematically reviewed the literature on frailty in patients with brain tumor with respect to 3 questions: What methods of frailty assessment have been applied to patients with brain tumor? What thresholds have been defined to distinguish between different levels of frailty? What clinical outcomes does frailty predict in patients with brain tumor? METHODS: A literature search was conducted using PubMed, Embase, The Cochrane Library, Web of Science, Scopus, and ClinicalTrials.gov. Included studies were specific to patients with brain tumor, used a validated instrument to assess frailty, and measured the impact of frailty on postoperative outcomes. RESULTS: Of 753 citations, 21 studies met our inclusion criteria. Frailty instruments were studied, in order of frequency reported, including the 5-factor modified frailty index, 11-factor modified frailty index, Johns Hopkins Adjusted Clinical Groups frailty-defining diagnosis indicator, and Hopkins Frailty Score. Multiple different conventions and thresholds were reported for distinguishing the levels of frailty. Clinical outcomes associated with frailty included mortality, survival, complications, length of stay, charges, costs, discharge disposition, readmissions, and operative time. CONCLUSIONS: Frailty is an increasingly popular concept in patients with brain tumor that is associated with important clinical outcomes. However, the extant literature is largely comprised of retrospective studies with heterogeneous definitions of frailty, thresholds for defining levels of frailty, and patient populations. Further work is needed to understand best practices in assessing frailty in patients with brain tumor and applying these concepts to clinical practice.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Huq S, Liu J, Romano R, et al. Frailty in Patients Undergoing Surgery for Brain Tumors: A Systematic Review of the Literature. World Neurosurg. 2022. PMID: 35843574. doi:10.1016/j.wneu.2022.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。